# Implantation or Injectable Dosage Form New Animal Drugs; Progesterone and Estradiol Benzoate
> **Food and Drug Administration** · Final rule. · Published 2004-12-02 · Effective 2004-12-02 · 69 FR 70054
## Document
- **Document number:** 04-26530
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 69 FR 70054
- **CFR reference:** 21 CFR 522
- **Publication date:** 2004-12-02
- **Effective date:** 2004-12-02
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of supplemental new animal drug applications (NADAs) filed by Fort Dodge Animal Health, Division of Wyeth, and Ivy Laboratories, Division of Ivy Animal Health, Inc. The supplemental NADAs provide for the addition of statements to labeling of subcutaneous implants containing progesterone and estradiol benzoate warning against the use of these products in calves to be processed for veal.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2004/12/02/04-26530/implantation-or-injectable-dosage-form-new-animal-drugs-progesterone-and-estradiol-benzoate)
---
*AI Analytics · CC0 1.0*